Home > Healthcare > Medical Devices > Diagnostic Devices > Carrier Screening Market

Carrier Screening Market Trends

Report ID: GMI5759
Published Date: May 2023
Report Format: PDF

Download Free Sample

Carrier Screening Market Trends

Increasing prevalence of genetic disorders, rise in maternal age resulting in pregnancy complications and increase in awareness level for presence of genetic risks in people with medical history are anticipated to augment the industry growth over the forecast timeframe. Owing to such factors, there is a growing need for proper, precise, and early diagnosis of genetic disorders among young couples in reproductive age group. Thus, if one or both the parents belong to certain ethnicities that are at high risk of genetic complications, the doctor may likely to recommend carrier screening for such couples.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for carrier screening was valued at around USD 2 billion in 2023 and is estimated to amass more than USD 6 billion by the end of 2032 owing to the increasing awareness of the possibility of genetic risks among couples.

The expanded carrier screening segment is expected to account for around USD 3.7 billion in 2032 attributed to the increasing product use in screening of multiple genetic disorders.

North America market for carrier screening is projected to reach over USD 2.3 billion by 2032 driven by the high R&D spending for different genetic complications and the availability of a wide range of carrier screening products.

Fulgent Genetics Inc., Thermo Fisher Scientific Inc., BGI Genomics, InVitae Corporation, Quest Diagnostics Inc., Illumina Inc., and Myriad Genetics, Inc. are some of the top companies in the global carrier screening market.